Document Detail


Can We Predict the Outcome of 532 nm Laser Photoselective Vaporization of the Prostate? Time to Event Analysis.
MedLine Citation:
PMID:  22998906     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: We evaluated the safety, efficacy and predictability of the long-term outcome of GreenLight™ (532 nm laser) photoselective vaporization of the prostate to treat patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. MATERIALS AND METHODS: We performed a longitudinal study of patients who underwent GreenLight (532 nm laser) photoselective vaporization of the prostate at our center between June 2002 and November 2011. All patient data were prospectively maintained in the prostate unit database. Two types of laser equipment were used, including the KTP in 91 cases (31.6%) and the GreenLight HPS™ in 197 (68.4%). RESULTS: Larger glands were treated with HPS and KTP photoselective vaporization (mean ± SD volume 45.6 ± 22.5 and 39.6 ± 15.2 ml, respectively, p <0.05). After photoselective vaporization with the KTP laser, we noted a 59.1% and 61.8% decrease in the International Prostate Symptom Score, and a 140.7% and 118.4% improvement in the maximal urine flow rate at 1 and 5 years, respectively. Similarly, after prostate vaporization with the HPS we observed a 65.1% and 62.1% decrease in the International Prostate Symptom Score, and a 123.1% and 107.3% improvement in the maximal urine flow rate at 1 and 4 years, respectively. At a mean of 40.5 months (range 3 to 114) of followup reoperation was indicated in 7.6% of cases. The overall rates of bladder neck contracture, de novo urethral stricture and residual/recurrent adenoma were 3.4% (10 cases), 2.1% (6) and 2.1% (6) with no statistically significant difference between vaporization with the KTP and HPS lasers. Most adverse events occurred during year 1 postoperatively. More bladder neck contractures developed after vaporization was done in smaller glands (p <0.05). More cases with residual prostatic adenoma had a prostate volume of 50 ml or greater vs less than 50 ml (4 of 71 or 5.6% vs 2 of 207 or 0.96%). CONCLUSIONS: GreenLight (532 nm laser) photoselective vaporization of the prostate seems to be safe and effective for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A long lasting, successful outcome is predictable. With careful surveillance during year 1 postoperatively and early intervention for adverse events, a sustainable functional outcome could be achieved without re-treatment.
Authors:
Ahmed M Elshal; Hazem M Elmansy; Mostafa M Elhilali
Related Documents :
19674706 - Feasibility study of short-term effects of chiropractic manipulation on older adults wi...
3819886 - Predictors of successful alcohol rehabilitation in an air force population.
10807486 - A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherap...
23932216 - Lifetime risk of blindness in open-angle glaucoma.
15846666 - Clotting factor concentrates given to prevent bleeding and bleeding-related complicatio...
24686046 - Ultrasound-guided supraclavicular brachial plexus block: single versus triple injection...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-18
Journal Detail:
Title:  The Journal of urology     Volume:  -     ISSN:  1527-3792     ISO Abbreviation:  J. Urol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Affiliation:
Division of Urology, Department of Surgery, McGill University, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stepwise Description and Outcomes of Bladder Neck Sparing During Robot-Assisted Laparoscopic Radical...
Next Document:  A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothe...